Linscomb & Williams Inc. lowered its position in shares of Vanguard Total Bond Market ETF (NASDAQ:BND – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,604 shares of the company’s stock after selling 397 […]
Linscomb & Williams Inc. decreased its holdings in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,871 shares of the basic materials company’s stock after selling 497 […]
Linscomb & Williams Inc. cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,427 shares of the biopharmaceutical company’s stock after selling 265 shares during the quarter. Linscomb & […]
Linscomb & Williams Inc. decreased its holdings in SPDR S&P 400 Mid CapGrowth ETF (NYSEARCA:MDYG – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,545 shares of the company’s stock after selling 915 shares […]
Linscomb & Williams Inc. reduced its stake in Starbucks Co. (NASDAQ:SBUX – Free Report) by 83.7% during the 4th quarter, Holdings Channel reports. The fund owned 12,357 shares of the coffee company’s stock after selling 63,597 shares during the period. Linscomb & Williams Inc.’s holdings in Starbucks were worth $1,186,000 at the end of the […]